Equity Incentive Plan (Details 2) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Research and development | $ 2,623,280 | $ 1,607,819 | ||||
| Stock-based compensation expense | $ 1,416,691 | $ 0 | ||||
| Stock Option [Member] | ||||||
| General and administrative | $ 30,075 | $ 0 | 310,046 | 0 | ||
| Research and development | 112,580 | 0 | 1,106,645 | 0 | ||
| Stock-based compensation expense | $ 142,655 | $ 0 | $ 1,416,691 | $ 0 | ||
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|